212 related articles for article (PubMed ID: 32929463)
1. Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission.
Møller-Bisgaard S; Georgiadis S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Ørnbjerg LM; Glinatsi D; Møller J; Boesen M; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen HS; Østergaard M
Rheumatology (Oxford); 2021 Jan; 60(1):380-391. PubMed ID: 32929463
[TBL] [Abstract][Full Text] [Related]
2. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Ørnbjerg LM; Glinatsi D; Møller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen HS; Østergaard M
JAMA; 2019 Feb; 321(5):461-472. PubMed ID: 30721294
[TBL] [Abstract][Full Text] [Related]
3. Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol.
Paulshus Sundlisæter N; Olsen IC; Aga AB; Hammer HB; Uhlig T; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA;
Rheumatology (Oxford); 2018 Nov; 57(11):2022-2031. PubMed ID: 30053199
[TBL] [Abstract][Full Text] [Related]
4. Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Christensen R; Ørnbjerg LM; Glinatsi D; Møller JM; Boesen M; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Larsen L; Jurik AG; Thomsen HS; Østergaard M
Scand J Rheumatol; 2022 Jul; 51(4):268-278. PubMed ID: 34474649
[TBL] [Abstract][Full Text] [Related]
5. Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg BJ; Boesen M; Hetland ML; Christensen R; Møller J; Krogh NS; Stengaard-Pedersen K; Østergaard M
Trials; 2015 Apr; 16():178. PubMed ID: 25896862
[TBL] [Abstract][Full Text] [Related]
6. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
[TBL] [Abstract][Full Text] [Related]
7. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
[TBL] [Abstract][Full Text] [Related]
8. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
Paulshus Sundlisæter N; Aga AB; Olsen IC; Hammer HB; Uhlig T; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA;
Ann Rheum Dis; 2018 Oct; 77(10):1421-1425. PubMed ID: 29934373
[TBL] [Abstract][Full Text] [Related]
9. Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial.
Ahmad HA; Baker JF; Østergaard M; Ye J; Emery P; Conaghan PG
Adv Ther; 2019 Sep; 36(9):2384-2393. PubMed ID: 31278695
[TBL] [Abstract][Full Text] [Related]
10. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.
Lee YC; Cui J; Lu B; Frits ML; Iannaccone CK; Shadick NA; Weinblatt ME; Solomon DH
Arthritis Res Ther; 2011 Jun; 13(3):R83. PubMed ID: 21651807
[TBL] [Abstract][Full Text] [Related]
11. Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort.
Sewerin P; Vordenbaeumen S; Hoyer A; Brinks R; Buchbender C; Miese F; Schleich C; Klein S; Schneider M; Ostendorf B
BMC Musculoskelet Disord; 2017 Apr; 18(1):163. PubMed ID: 28420375
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
Castrejón I; Dougados M; Combe B; Fautrel B; Guillemin F; Pincus T
J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
[TBL] [Abstract][Full Text] [Related]
13. Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity.
Gandjbakhch F; Haavardsholm EA; Conaghan PG; Ejbjerg B; Foltz V; Brown AK; Døhn UM; Lassere M; Freeston JE; Olsen IC; Bøyesen P; Bird P; Fautrel B; Hetland ML; Emery P; Bourgeois P; Hørslev-Petersen K; Kvien TK; McQueen FM; Østergaard M
J Rheumatol; 2014 Feb; 41(2):398-406. PubMed ID: 24334647
[TBL] [Abstract][Full Text] [Related]
14. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
Lillegraven S; Prince FH; Shadick NA; Bykerk VP; Lu B; Frits ML; Iannaccone CK; Kvien TK; Haavardsholm EA; Weinblatt ME; Solomon DH
Ann Rheum Dis; 2012 May; 71(5):681-6. PubMed ID: 21994234
[TBL] [Abstract][Full Text] [Related]
15. Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis.
Conaghan PG; Østergaard M; Troum O; Bowes MA; Guillard G; Wilkinson B; Xie Z; Andrews J; Stein A; Chapman D; Koenig A
Arthritis Res Ther; 2019 Oct; 21(1):214. PubMed ID: 31639034
[TBL] [Abstract][Full Text] [Related]
16. Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials.
Keystone EC; Ahmad HA; Yazici Y; Bergman MJ
Rheumatology (Oxford); 2020 Aug; 59(8):2090-2098. PubMed ID: 31819995
[TBL] [Abstract][Full Text] [Related]
17. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
[TBL] [Abstract][Full Text] [Related]
18. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
[TBL] [Abstract][Full Text] [Related]
19. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
[TBL] [Abstract][Full Text] [Related]
20. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
